IQVIQVIA Holdings Inc.

IQV Stock Price, Valuation & Chart | IQVIA Holdings Inc.

Compare

$263.84+5.49 (+2.13%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research IQV intrinsic value IQV calculated fair value vs price

Overview Financials Dividends Ratios

IQV Historical price chart

IQV Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization43.43B

PE Ratio21.75

EPS12.13

Trading Volume1.11M

Today's High/Low266.08/257.18

Dividend Yield0.00

52 Week High/Low266.08/154.5

Shares Outstanding164.60M

IQV Financial Statement

IQV Analyst ratings

IQV Analysis & performance metrics

IQV Company profile

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the…

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a…

IQV Management team

Name

Position

Keriann Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

Jim Berkshire

Executive Vice President of Global Technology & Operations

Jeffrey A. Spaeder M.D.

Senior Vice President, Global Chief Medical & Scientific Officer

Trudy Stein

Chief Human Resources Officer & Executive Vice President

W. Richard Staub III

President of Research & Development Solutions

Ari BousbibCEO

Chief Executive Officer & Chairman

Eric M. Sherbet J.D.

Executive Vice President, General Counsel & Secretary

Kerri Joseph

SVice President of Investment Relation & Treasury

Name

Position

Keriann Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

Jim Berkshire

Executive Vice President of Global Technology & Operations

Jeffrey A. Spaeder M.D.

Senior Vice President, Global Chief Medical & Scientific Officer

Trudy Stein

Chief Human Resources Officer & Executive Vice President

W. Richard Staub III

President of Research & Development Solutions

Ari BousbibCEO

Chief Executive Officer & Chairman

Eric M. Sherbet J.D.

Executive Vice President, General Counsel & Secretary

Kerri Joseph

SVice President of Investment Relation & Treasury

Management Team

Keriann Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

Jim Berkshire

Executive Vice President of Global Technology & Operations

Jeffrey A. Spaeder M.D.

Senior Vice President, Global Chief Medical & Scientific Officer

Trudy Stein

Chief Human Resources Officer & Executive Vice President

W. Richard Staub III

President of Research & Development Solutions

Ari BousbibCEO

Chief Executive Officer & Chairman

Eric M. Sherbet J.D.

Executive Vice President, General Counsel & Secretary

Kerri Joseph

SVice President of Investment Relation & Treasury

Management

Keriann Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

Jim Berkshire

Executive Vice President of Global Technology & Operations

Jeffrey A. Spaeder M.D.

Senior Vice President, Global Chief Medical & Scientific Officer

Trudy Stein

Chief Human Resources Officer & Executive Vice President

W. Richard Staub III

President of Research & Development Solutions

Ari BousbibCEO

Chief Executive Officer & Chairman

Eric M. Sherbet J.D.

Executive Vice President, General Counsel & Secretary

Kerri Joseph

SVice President of Investment Relation & Treasury

Total 8 executives

IQV Frequently asked questions

What is IQVIA Holdings Inc. (IQV) Stock Price?

Current stock price of IQVIA Holdings Inc. (IQV) stock is $263.84. The stock price is +2.13% higher in the session. The intraday range can be seen from this page. Volume of IQVIA Holdings Inc. (IQV) stock is 1.11M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the IQVIA Holdings Inc. (IQV) stock price going up or down today?

The stock price of IQVIA Holdings Inc. (IQV) can change with earnings, company news, and overall market sentiment. IQVIA Holdings Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the IQVIA Holdings Inc. stock expensive at its current price?

Whether IQVIA Holdings Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IQV on this page is 21.75. EPS on this page is 12.13. Compare those figures with peers and growth expectations before deciding if the current IQVIA Holdings Inc. price is justified.

How has the stock price of IQVIA Holdings Inc. (IQV) performed historically?

Historical performance for IQVIA Holdings Inc. (IQV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IQV reacted to past earnings and market events.

Should I buy IQVIA Holdings Inc. (IQV) stock, at this price?

Buying IQVIA Holdings Inc. (IQV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.